COA, MSDS, TDS & DMF Explained: API Documentation Guide
Pharmaceutical API procurement is a technical B2B activity where product identity, CAS number, grade, documentation, destination country, and commercial feasibility all matter. This CLAYRAS guide explains the topic from a buyer-focused and compliance-aware perspective.
Why this matters for API buyers
When procurement teams evaluate API sourcing from India, they usually review more than price. They check source reliability, pharmacopoeial grade, COA/MSDS availability, documentation expectations, packaging, logistics feasibility, and destination-market regulatory context.
Key points to review
- Confirm the exact API name, CAS number, and therapeutic category.
- Clarify required grade such as IP, BP, USP, EP, or other specifications.
- Discuss COA, MSDS/SDS, TDS, DMF, CEP, GMP, GLP, and other document expectations early.
- Share target quantity, destination country, shipment timeline, buyer type, and repeat requirement possibility.
- Review MOQ, lead time, packing size, incoterms, and logistics feasibility product-wise.
CLAYRAS approach
CLAYRAS supports structured API export communication from India with a documentation-aware approach. Every inquiry is reviewed around product identity, destination-market context, required documents, source feasibility, and commercial alignment before final confirmation.
Buyer recommendation
For faster review, buyers should share API name, CAS number, grade, quantity, destination country, required documentation, expected timeline, and company details. A clear inquiry reduces delays and improves the accuracy of product-wise review.
